# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066907
Filing Date
2025-05-08
Accepted
2025-05-08 16:05:22
Documents
76
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | eypt-20250331.htm iXBRL | 10-Q | 1963919
2 | EX-10.1 | eypt-ex10_1.htm | EX-10.1 | 66079
3 | EX-31.1 | eypt-ex31_1.htm | EX-31.1 | 14583
4 | EX-31.2 | eypt-ex31_2.htm | EX-31.2 | 15052
5 | EX-32.1 | eypt-ex32_1.htm | EX-32.1 | 6615
6 | EX-32.2 | eypt-ex32_2.htm | EX-32.2 | 6724
| Complete submission text file | 0000950170-25-066907.txt |  | 8799411

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | eypt-20250331.xsd | EX-101.SCH | 1313453
78 | EXTRACTED XBRL INSTANCE DOCUMENT | eypt-20250331_htm.xml | XML | 1601159

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51122 | Film No.: 25925926
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)